Latest News about VRTX
Recent news which mentions VRTX
From InvestorPlace
 
   Better Big Biotech Buy: Vertex vs. Biogen
   
  
  
  July 24, 2023
  From Motley Fool
 
   Barron's Weekend Stock Picks: Barbie Bonanza, Vertex's Promising Drug And Tesla Doubts
   
  
  
  July 22, 2023
  From Benzinga
 
   The Best Stocks to Invest $5,000 in Right Now
   
  
  
  July 22, 2023
  From Motley Fool
 
   B of A Securities Maintains Buy Rating for Vertex Pharmaceuticals: Here's What You Need To Know
   
  July 21, 2023
  Tickers 
   VRTX
  
  
  From Benzinga
 
   Is Now a Good Time to Buy CRISPR Therapeutics?
   
  
  
  July 21, 2023
  From Motley Fool
 
   My Take: 4 Strong Growth Stocks to Buy This Week
   
  
  
  July 20, 2023
  From Motley Fool
 From InvestorPlace
 From Benzinga
 From Motley Fool
 
   3 No-Brainer Stocks to Buy With $400 Right Now
   
  
  
  July 19, 2023
  From Motley Fool
 
   2 Monster Stocks to Buy Without Any Hesitation
   
  
  
  July 17, 2023
  From Motley Fool
 
   3 Pharma Stocks That AI is Loving in July
   
  
  July 13, 2023
  Tags
   NASDAQ:CRSP,NYSE:PFE,NASDAQ:SGEN,NASDAQ:BEAM,NASDAQ:VRTX,NASDAQ:REGN,NASDAQ:NTLA
   PFE
   Market News
  
  From InvestorPlace
 From Motley Fool
 
   3 Top Biotech Stocks Defying the Bear Market
   
  
  
  July 13, 2023
  From Motley Fool
 From Motley Fool
 
   3 Biotech Stocks That AI is Loving in July
   
  
  
  July 12, 2023
  From InvestorPlace
 From Motley Fool
 
   2 Top Healthcare Stocks Defying the Bear Market
   
  
  
  July 11, 2023
  From Motley Fool
 
   Sitting on Cash? These 2 Stocks Are Great Buys
   
  
  
  July 11, 2023
  From Motley Fool
 
   Here's How Much $1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
   
  July 10, 2023
  Tickers 
   VRTX
  
  
  From Benzinga
 
   Is Johnson & Johnson Stock a Buy Now?
   
  
  
  July 09, 2023
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   3 No-Brainer Stocks You Can Buy Right Now
   
  
  
  July 08, 2023
  From Motley Fool
 
   Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades'
   
  
  
  July 07, 2023
  From Benzinga
 
   2 Growth Stocks That Might Be Too Cheap to Ignore
   
  
  
  July 06, 2023
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

